Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Hakan Kardes Sells 10,500 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hakan Kardes sold 10,500 shares of the stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $14.99, for a total transaction of $157,395.00. Following the sale, the insider now directly owns 309,944 shares in the company, valued at $4,646,060.56. This trade represents a 3.28 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Hakan Kardes also recently made the following trade(s):

• On Friday, January 24th, Hakan Kardes sold 14,500 shares of Alignment Healthcare stock. The stock was sold at an average price of $14.98, for a total transaction of $217,210.00.
• On Wednesday, November 27th, Hakan Kardes sold 35,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.80, for a total value of $448,000.00.
• On Monday, November 4th, Hakan Kardes sold 20,500 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.06, for a total value of $267,730.00.
• On Friday, November 1st, Hakan Kardes sold 4,500 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.98, for a total value of $58,410.00.

Alignment Healthcare Trading Up 2.7 %

Shares of ALHC stock opened at $14.97 on Friday. Alignment Healthcare, Inc. has a twelve month low of $4.46 and a twelve month high of $15.05. The stock has a market cap of $2.87 billion, a price-to-earnings ratio of -19.44 and a beta of 1.45. The company’s 50-day moving average price is $12.13 and its 200-day moving average price is $10.99. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings results on Tuesday, October 29th. The company reported ($0.14) earnings per share for the quarter, meeting the consensus estimate of ($0.14). The business had revenue of $692.43 million during the quarter, compared to analysts’ expectations of $662.11 million. Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. The business’s revenue for the quarter was up 51.6% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.19) EPS. As a group, equities analysts predict that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Institutional Investors Weigh In On Alignment Healthcare

Several institutional investors and hedge funds have recently modified their holdings of the company. Creative Planning grew its position in Alignment Healthcare by 20.0% in the 3rd quarter. Creative Planning now owns 12,442 shares of the company’s stock valued at $147,000 after acquiring an additional 2,072 shares in the last quarter. R Squared Ltd purchased a new position in shares of Alignment Healthcare in the fourth quarter valued at approximately $55,000. SG Americas Securities LLC grew its holdings in shares of Alignment Healthcare by 11.7% in the fourth quarter. SG Americas Securities LLC now owns 49,272 shares of the company’s stock valued at $554,000 after purchasing an additional 5,163 shares in the last quarter. nVerses Capital LLC purchased a new stake in Alignment Healthcare during the 3rd quarter worth approximately $95,000. Finally, The Manufacturers Life Insurance Company lifted its holdings in Alignment Healthcare by 20.9% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 55,531 shares of the company’s stock worth $434,000 after buying an additional 9,595 shares in the last quarter. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Analyst Ratings Changes

ALHC has been the topic of a number of research analyst reports. Stephens reissued an “overweight” rating and issued a $17.00 price target on shares of Alignment Healthcare in a research note on Thursday, January 2nd. UBS Group boosted their target price on shares of Alignment Healthcare from $9.00 to $12.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 30th. Barclays raised their price target on shares of Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 30th. Stifel Nicolaus boosted their price objective on Alignment Healthcare from $14.00 to $16.00 and gave the stock a “buy” rating in a research note on Tuesday, January 14th. Finally, KeyCorp started coverage on Alignment Healthcare in a research report on Friday, October 11th. They issued a “sector weight” rating on the stock. One analyst has rated the stock with a sell rating, two have given a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $11.88.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.